Palvella Therapeutics, Inc (PVLA) — Defensive Interval Ratio
Palvella Therapeutics, Inc (PVLA) has a Defensive Interval Ratio of 2221 days as of March 2026. Defensive assets of $55.46 Million (cash $-, short-term investments $55.46 Million, receivables $-) cover 2221 days of daily cash needs of $24.97K/day. Check Palvella Therapeutics, Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Palvella Therapeutics, Inc Defensive Interval Ratio (2020–2025)
This chart shows how Palvella Therapeutics, Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 2221 days, meaning defensive assets of $55.46 Million can fund 2221 days of operations without new revenue. Also explore Palvella Therapeutics, Inc (PVLA) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Palvella Therapeutics, Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Palvella Therapeutics, Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Palvella Therapeutics, Inc market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 0 days | $0.00 | $31.08K/day | $- | $- | ▼ -71 days |
| 2024 | 71 days | $2.34 Million | $32.98K/day | $- | $- | ▲ +71 days |
| 2023 | 0 days | $0.00 | $6.47K/day | $- | $- | ▼ -1663 days |
| 2022 | 1663 days | $26.34 Million | $15.84K/day | $- | $20.53 Million | ▲ +1639 days |
| 2021 | 24 days | $3.31 Million | $138.52K/day | $- | $- | ▼ -4 days |
| 2020 | 28 days | $1.71 Million | $60.67K/day | $- | $- | — |